- Home
- Site Contents
- Our Founder
- Governance
- Faculty
- Strategic Plan
- Core Values
- Resources
- Programs - Research
- Programs - Education
- Programs - Service
- Clinical Trials
- Other Activities
- Press Releases 1980-1999
- Press Releases 2000-2009
- Press Releases 2010-2014
- Press Releases 2015-2019
- Press Releases 2020-2024
- Press Releases 2025-2029
- Blogs
- Podcasts
- LinkedIn Posts
- Conferences 2013-2017
- Conferences 2018
- Conferences 2019
- Conferences 2020
- Conferences 2021
- Conferences 2022
- Conferences 2023
- Conferences 2024
- Conferences 2025
- Patents
- Books & Monographs
- Book Contributions -1
- Book contributions -2
- Refereed Articles - 1
- Refereed Articles -2
- Refereed Articles - 3
- Refereed Articles - 4
- Abstracts 2013-2017
- Abstracts 2018-2019
- Abstracts 2020-2025
- Philanthropy
- Privacy Policy
ABSTRACTS (2018-2019)
2018
A. L. Fymat, Nanotechnology May Provide New Hope for Brain Cancer Therapy, Plenary Lecture delivered at the Cancer 2018 International Conference & Exhibition on Cancer & Therapeutics, Las Vegas, January 29-31, 2018.
A. L. Fymat, Nanotechnology May Provide New Hope for Brain Cancer Therapy, 11th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Granada, Spain, March 19-21, 2018.
A. L. Fymat, Therapeutics Delivery Behind, Through and Beyond the Blood Bain Barrier, Keynote Lecture delivered at the 16th International Conference & Exhibit ion on Pharmaceutics & Novel Drug Delivery Systems, Berlin, Germany, March 19-21, 2018.
A. L. Fymat, Glioblastoma Treatments: Where Do We Stand? 10thAnnual International Congress of Antibodies-2018 (ICA-2018), Stream 3: Antibodies for Cancer Therapy, Washington, D.C., U.S.A., March 23-25, 2018.
A. L. Fymat, Immunotherapy of Brain Cancers and Neurological Disorders, BIT's 9th World DNA Day, Dalian, China, April 25-27, 2018,
A. L. Fymat, Nanobiotechnology-based Drug Delivery Through the Blood Brain Barrier for the Treatment of Neurological Disorders, BIT 8thAnnual International Symposium on Drug Delivery Systems, St Petersburg, Russia, July 19-21,2018.
A. L. Fymat, Nanotechnology May Provide New Hope for Brain Cancer Therapy, Invited lecture presented at the World Congress on Cancer Science and Therapy, Cancer 2018. Boston, U.S.A, August 13-14, 2018
A. L. Fymat, Glioblastoma Treatment: Where Do We Stand? Plenary Lecture presented at the BIT 16th Annual Congress of Drug Discovery Science and Technology 2018, Boston, Massachusetts, U.S.A., August 16-19, 2018.
A. L. Fymat, Nanotechnology May Provide New Hope for Brain Cancer Therapy, Keynote Lecture at the International Conference on Nanomedicine and Nanotechnology, Rome, Italy, August 20-21, 2018.
A. L. Fymat, A Disrupted Blood Brain Barrier May Allow Potentially New Epileptic Treatments, Keynote presentation at the Joint Event on 4th International Conference on Epilepsy & Treatment & 4th World Congress on Parkinson's & Huntington's Disease, Zurich, Switzerland, August 29-30, 2018.
A. L. Fymat, Immunotherapy Therapy of Brain Cancers, Keynote Lecture presented at the 24th Global Meet on Cancer Research & Oncology, Toronto, Canada, September 14-15, 2018.
A. L. Fymat, Extending Drug Delivery Across the Blood Brain Barrier, Keynote Lecture, 15th International Conference on Pharmaceutical Formulations & Drug Delivery, Philadelphia September 16-18, 2018. Journal of Pharmaceutical Care & Health Systems Vol 5, doi: 104172/2376-0419-C2-028.
A. L. Fymat, Roles of Nanomedicine in Clinical Neuroscience, Keynote Presentation at the 15th International Conference on Pharmaceutical Formulations & Drug Delivery, Philadelphia, USA, September 17-18, 2018,
A. L. Fymat, Complementing Indigenous and Traditional Remedies with Modern Therapies Against Chronic Diseases, Keynote presentation at the International Conference on Traditional Medicine, Pharmacy, Nursing & Health Sciences, Osaka, Japan, September 28-30, 2018.
A. L. Fymat, Introductory Remarks from the Chairman of the Scientific Committee, Joint 5th International Conference of the Society for the Advancement of Science in Africa and the 2ndBiennial Conference of the University of Rwanda, Kigali, Rwanda, October 4-6, 2018.
A. L. Fymat, Precision Medicine: A New Paradigm in Medicine and Health Care, Keynote at the Joint 5thInternational Conference of the Society for the Advancement of Science in Africa and the 2ndBiennial Conference of the University of Rwanda, Kigali, Rwanda, October 4-6, 2018.
A. L. Fymat, Role of the Blood Brain Barrier in Epilepsy and Epileptic Treatments, Invited presentation at the World Congress on Epilepsy and Neuronal Synchronization, London, England, October 15-16, 2018.
A. L. Fymat, A Disrupted Blood Brain Barrier May Allow Potentially New Epileptic Treatments, presented at “Joint Event on 4th International Conference on Epilepsy & Treatment & 4th World Congress on Parkinson's & Huntington's Disease”.
A. L. Fymat, Leveraging the Blood Brain Barrier Disruption for the Treatment of Parkinson and Other Movement Disorders, 3rd International Conference on Parkinson's Disease & Movement Disorders, New York, N.Y., U.S.A., October 19-20, 2018.
A. L. Fymat, Neurological Disorders: Application of Nanobiotechnology to Drug Delivery Through the Blood Brain Barrier, Invited presentation at the Pharma and Novel Drug Delivery Systems, Moscow, Russia, October 24-26, 2018.
A. L. Fymat, Immunotherapy of Brain Cancers and Neurological Disorders, BIT's 9th World Congress General Convention 2018, Singapore, November 13-15, 2018.
A. L. Fymat, Nanobiotechnology for the Treatment of Neurological Disorders, Invited presentation at the 23rd International Conference on Pharmaceutical Biotechnology, Rome, Italy, December 10-11, 2018.
A. L. Fymat, Roles of Nanomedicine in Clinical Neuroscience, EuroSciCon 2018, Nanoengineering and Technology, Rome, Italy, December 10-11, 2018.
2019
A. L. Fymat, Nanotechnology in the Treatment of Glioblastomas and Neurodegenerative Disorders, Invited keynote presentation at the 22nd International Conference on Advanced Nanoscience and Nanotechnology, Paris, France, February 18-19, 2019.
A. L. Fymat, Immunotherapy of Brain Cancers and Neurological Disorders, Keynote presentation at the Pharma R&D 2019 International Conference on PharmaScience Research & Development, Paris, France, March 3-4, 2019.
A.L. Fymat, Dementia: Alzheimer as a Run-Away Autoimmune Disease, Invited Presentation, at the 12thInternational Congress on Vascular Dementia and Dementia, London, U.K., March 14-16, 2019.
A. L. Fymat, Alzheimer: An Autoimmune Disorder Gone Rogue, Keynote presentation at the 13thWorld Congress on Dementia and Alzheimer Disease”, Melbourne, Australia, March 25-26, 2019.
A. L. Fymat, Nanotechnology May Provide New Hope for Brain Cancer Therapy, 2nd International Conference on Pharmaceutical Nanotechnology & Nanomedicine 2019, New York, N.Y., U.S.A., March 20-21, 2019.
A. L. Fymat, Surgical and Non-Surgical Management and Treatment of Glioblastomas, 2ndInternational Conference on Pathology and Surgical Pathology, Melbourne, Australia, March 27-28, 2019
A. L. Fymat, Dementia Treatment: Where Do We Stand? Conference on Neurology and Psychiatry, Prague, Czech Republic, April 25-26, 2019.
A. L. Fymat, Immunotherapy of Brain Cancers and Neurological Disorders, International Conference on Pharmatech Research & Development, Paris, France, May 4-6, 2019.
A. L. Fymat, 4thInternational Conference on Nanomedicine and Nanotechnology, London, England, May 20-21, 2019.
A. L. Fymat,Is Alzheimer's an Autoimmune Disease Gone Rogue? Keynote Lecture presented at the 6thInternational Conference on Brain Disorders and Therapeutics, Paris, France, July 1-2, 2019.
A.L. Fymat, Can Africa Manufacture Its Drugs and Vaccines? Commonwealth Africa Summit, The Africa Forum, Toronto, Canada, September 13-15, 2019.
A. L. Fymat, Immunotherapy of Brain Cancers, Global Meet on Cancer Research and Oncology, Toronto, Canada, September 14-15, 2019.
A. L. Fymat, Is Alzheimer's a Runaway Autoimmune Disease? 13th World Congress of Dementia and Alzheimer Disease, Paris, France, September 16-17, 2019, Paris.
A. L. Fymat, Nanobiotechnology-based Drug Delivery for the Treatment of Neurodegenerative Diseases, Conference on Advanced Pharmaceutics & Clinical Research, Paris, France, November 4-5, 2019.
A. L. Fymat, Dementia Treatment: Where Do We Stand, Invited Keynote Lecture presented at the International Conference on Neurology and Psychiatry, Paris, France, November 28-29, 2019.
A. L. Fymat, Enhancing Drug Delivery Across the Brain Protective Barriers , 2019.